This inventor holds 1 USPTO granted patent. Top assignee: Laboratoires Serono S.a.. Active years: 2009.
Company Filing History:
Years Active: 2009
Title: Pierre-Andre Pittet: Innovator in Metabolic Disorder Treatments
Introduction
Pierre-Andre Pittet is a notable inventor based in Gilly, Switzerland. He has made significant contributions to the field of medical science, particularly in the treatment of metabolic disorders. His innovative work focuses on developing compounds that can modulate protein tyrosine phosphatases, which play a crucial role in various metabolic processes.
Latest Patents
Pierre-Andre Pittet holds 1 patent for his invention titled "Substituted methylene amide derivatives as modulators of protein tyrosine phosphatases (PTPs)." This patent addresses the treatment and prevention of metabolic disorders mediated by insulin resistance or hyperglycemia, including diabetes types I and II, inadequate glucose tolerance, and obesity. The invention specifically relates to the use of substituted methylene amide derivatives to inhibit the activity of PTPs, offering a potential method for treating diabetes type II and regulating appetite in mammals.
Career Highlights
Pierre-Andre Pittet is associated with Laboratoires Serono S.A., where he has been instrumental in advancing research related to metabolic disorders. His work has contributed to a better understanding of how certain compounds can influence insulin resistance and related conditions.
Collaborations
Throughout his career, Pierre-Andre has collaborated with notable colleagues such as Patrick Gerber and Jerome Gonzalez. These collaborations have further enriched his research and development efforts in the field of metabolic health.
Conclusion
Pierre-Andre Pittet's innovative contributions to the treatment of metabolic disorders highlight the importance of research in developing effective therapies. His work continues to pave the way for advancements in medical science, particularly in addressing conditions like diabetes and obesity.